Where Will Biogen Be in 5 Years?

Submitted by admin on January 16, 2022 - 3:56am

Source:

Motley Fool

News Tags:

Headline:

snippet:

The Centers for Medicare & Medicaid Services recently refused to grant a national coverage determination to Aduhelm.
Without national coverage, disappointing sales of Biogen's Alzheimer's disease drug probably won't improve.
Several drug candidates in late-stage development could help the company's top line start moving in the right direction again.

Search form